Table 2 Characteristics related to DBPCFC of the FAS population (N = 30)
Characteristics | |
|---|---|
Immediate reactions to CMP, N (%) | 22 (73.3) |
Types of immediate reactions to CMP, N (%) | |
Digestive signs | 19 (86.4) |
Local cutaneous signs | 7 (31.8) |
General cutaneous signs | 6 (27.3) |
Laryngeal edema | 2 (9.1) |
Bronchospasm | 1 (4.5) |
Delayed reactions to CMP, N (%) | 10 (33.3) |
Types of delayed reactions to CMP, N (%) | |
Digestive | 8 (80.0) |
Cutaneous | 5 (50.0) |
Cumulative dose of non-hydrolyzed CMP-based formula eliciting immediate reactions, median [minimum-maximum], ml | 15 [5–95] |
Time for eliciting immediate reactions, mean (± SD), minutes | 83.8 (16.1) |